Wait for longer-term data with Amgen's GLP-1, says Piper Sandler's Christopher Raymond ...

Related: Crazy-expensive weight loss drugs may soon see a major change In other news, The Biden Administration is set to ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs ...

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

According to CMS estimates, passage of the rule would open access to the weight-loss medications to 3.4 million potential new ...

A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...

The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GL ...

Dr. Caroline Apovian says you can still enjoy the holidays and festive meals while you're taking GLP-1 medications if you ...

TennCare is federally required to cover GLP-1 drugs; of the $118M in the cost increase request, more than $76 million would ...

Currently, Eli Lilly’s GLP-1 drugs Mounjaro and Zepbound (tirzepatide) are not on the FDA’s shortage list but compounded ...